NCCN adds Blue Earth's Posluma to its oncology guidelines
The NCCN has added Blue Earth Diagnostics' Posluma PET radiotracer to its guidelines for imaging prostate cancer.
-- The National Comprehensive Cancer Network (NCCN) has added Blue Earth Diagnostics ' Posluma (Flotufolastat F-18) PET radiotracer to its oncology guidelines f...
Read More
Other Stories in Health
- Review: Broken Country
- UQ researchers move closer to developing topical cream for skin cancers in transplant patients
- Ancient footprints reveal two hominin species coexisting 1.5 million years ago
- How to manifest anything you want? Neuroscientist's 6 steps to manifest right
- Review: Lies He Told Me
- Mandatory calorie labels boost awareness but fail to reduce intake
- New injection treatment could be a game-changer for people with asthma and COPD
- Scientists develop method to study malaria's sticky proteins
- Late-liver-stage malaria vaccine delivers 89% protection and boosts cellular immunity
.png)
